Hexima Ltd
HXL•Health Care•Biotechnology•Last updated: Dec 25
About
Hexima Ltd is a biotechnology company focused on the research and development of plant-derived proteins and peptides for applications in human therapeutics. The company is primarily engaged in developing treatments for fungal infections, with its lead product candidate targeting onychomycosis, a fungal infection of the nails. Hexima leverages its proprietary technology platform to discover and develop novel antifungal compounds.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- HXL
Related Shares
Investor Resources
Should you buy Hexima Ltd right now?
While HXL looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now